Boston introduces Promus Element drug eluting stent in Japan

Free Report

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.

By GlobalData

By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Boston Scientific has launched its Promus Element everolimus-eluting platinum chromium coronary stent system in Japan.

The Promus Element stent system features a platinum chromium (PtCr) alloy with an innovative stent design and advanced catheter delivery system, designed to provide improved drug-eluting stent performance for treating patients with coronary artery disease.

The stent system employs a proprietary PtCr alloy designed specifically for coronary stenting, which facilitates improved visibility, less recoil, conformability and higher radial strength.

The system incorporates a low-profile delivery system with a dual-layer balloon and bi-segment inner lumen catheter to provide precise stent delivery across challenging lesions and minimise balloon growth during inflation, for providing high-pressure stent deployment.

Currently, the Promus Element stent is available in a matrix of 74 sizes, ranging in diameter from 2.25mm to 4.00mm and from lengths of 8mm to 32mm on both monorail and over-the-wire catheter platforms. The firm expects that additional 32 mm and 38 mm stent lengths will be available in mid-2012.

Boston Scientific chief executive officer Hank Kucheman said the company provides physicians with a choice of two proven drug and polymer combinations on an innovative coronary stent platform.

Previously, the Platinum Small Vessel study demonstrated safety and efficacy outcomes for the 2.25mm Promus Element stent, including no stent thrombosis or myocardial infarction in treating small vessel coronary disease. The Platinum Long Lesion trial reported low rates of revascularisation while reporting no cardiac death, myocardial infarction or stent thrombosis in patients with long coronary lesions.

The European Commission and the US Food and Drug Administration cleared the Promus Element everolimus-eluting stent system in 2011. Boston Scientific intends to commence commercialising the product immediately in Japan.

The company is a developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.

Image: Promus Element everolimus-eluting platinum chromium stent system from Boston Scientific has launched in Japan.